The
Latest

back to news >

Our bench strength is in our extensive experience and team approach. We strive to facilitate each of our client’s needs through strategy, research, and collaboration.

May 23, 2022

Cognitive Research Corporation Names Alison Taber Senior Vice President, Data Management

Cognitive Research Corporation (CRC) today announced that Alison Taber is joining the company as a Senior Vice President, Data Management, effective May 23. CRC has been supporting clinical development for CNS-focused small to mid-size pharma, biotech, and medical device companies for over 16 years. The company has experienced explosive growth over the past five years as the CNS market has accelerated.

Taber is a veteran of the CRO industry, having served in various key executive roles within several notable CROS, including Quintiles, PPD, and Syneract (a Syneos Company). In her last role, she served as Senior Vice President, Project Management Operations.

As SVP Data Management, Alison will provide leadership and vision for the continuous improvement of data management operations and client service, as well as positioning the organization to achieve its strategic objectives.

“Alison is a fantastic leader and will provide vital assistance to our clinical teams as well as our clients.  CRC has built its reputation as a specialist clinical services operation steeped in scientific knowledge and clinical development expertise.  Alison will certainly add to our capabilities in both areas while also providing the “high-touch” service our clients need,” says C.G. (Chip) Gillooly, Chief Executive Officer of CRC.

About Cognitive Research Corporation:

CRC’s mission is to support innovative companies developing new medicines and therapies to improve mental health. As a leading neuroscience clinical research organization (CRO) and technology company, CRC works with sponsors, specialized clinical trial sites, and CNS experts to bring new drugs through rigorous testing and ultimately to market. For more information visit us here.